1. Home
  2. STXS vs GLO Comparison

STXS vs GLO Comparison

Compare STXS & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • GLO
  • Stock Information
  • Founded
  • STXS 1990
  • GLO 2006
  • Country
  • STXS United States
  • GLO United States
  • Employees
  • STXS 139
  • GLO N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GLO Finance/Investors Services
  • Sector
  • STXS Health Care
  • GLO Finance
  • Exchange
  • STXS Nasdaq
  • GLO Nasdaq
  • Market Cap
  • STXS 254.1M
  • GLO 242.5M
  • IPO Year
  • STXS 2004
  • GLO N/A
  • Fundamental
  • Price
  • STXS $2.77
  • GLO $5.69
  • Analyst Decision
  • STXS
  • GLO
  • Analyst Count
  • STXS 0
  • GLO 0
  • Target Price
  • STXS N/A
  • GLO N/A
  • AVG Volume (30 Days)
  • STXS 343.7K
  • GLO 170.5K
  • Earning Date
  • STXS 11-10-2025
  • GLO 01-01-0001
  • Dividend Yield
  • STXS N/A
  • GLO 11.38%
  • EPS Growth
  • STXS N/A
  • GLO N/A
  • EPS
  • STXS N/A
  • GLO N/A
  • Revenue
  • STXS $31,806,000.00
  • GLO N/A
  • Revenue This Year
  • STXS $30.92
  • GLO N/A
  • Revenue Next Year
  • STXS $43.27
  • GLO N/A
  • P/E Ratio
  • STXS N/A
  • GLO N/A
  • Revenue Growth
  • STXS 33.94
  • GLO N/A
  • 52 Week Low
  • STXS $1.54
  • GLO $4.08
  • 52 Week High
  • STXS $3.05
  • GLO $5.18
  • Technical
  • Relative Strength Index (RSI)
  • STXS 51.77
  • GLO 63.68
  • Support Level
  • STXS $2.73
  • GLO $5.54
  • Resistance Level
  • STXS $2.94
  • GLO $5.60
  • Average True Range (ATR)
  • STXS 0.09
  • GLO 0.06
  • MACD
  • STXS -0.03
  • GLO 0.00
  • Stochastic Oscillator
  • STXS 37.07
  • GLO 86.36

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About GLO Clough Global Opportunities Fund

Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.

Share on Social Networks: